Covid-19: Novavax vaccine shows 89% efficacy in UK trials
A mid-stage trial of the vaccine in South Africa showed 60% effectiveness among people who did not have HIV.
Full Article
Covid-19: Novavax vaccine shows 89% efficacy in UK trials
Khaleej Times
0 shares
2 views
You might like
Related news coverage
Johnson & Johnson And Novavax Vaccines May Not Sustain Herd Immunity Against Coronavirus Variants, New Trial Results Reveal
Gothamist
Johnson & Johnson's vaccine is being developed under the leadership of the subsidiary Janssen Vaccines in Leiden, The..
-
Serum Institute of India plans to launch Covovax by June: Adar Poonawalla
IndiaTimes
-
Coronavirus | Novavax vaccine highly effective, but not against South Africa variant
Hindu
-
Serum Institute applies to conduct local trial for Novavax vaccine: CEO
IndiaTimes
-
NVAX's Covid Jab Shows 89.3% Efficacy In UK Trial, AZRX Awaits Data, FDA Lifts Hold On BLCM Trial
RTTNews
Advertisement
More coverage
Covid-19 Variants And Vaccine Efficacy
Newsy
Watch VideoAs far as these mutations… it happens all the time for viruses, but with COVID there are a few of these “variants of..
-
Novavax’s Covid-19 vaccine nearly 90% effective in U.K. study, much less in South Africa
bizjournals
-
Novavax’s Vaccine Works Well — Except on Variant First Found in South Africa
NYTimes.com
-
Novavax COVID-19 vaccine demonstrates 89.3% efficacy in UK phase 3 trial
Jerusalem Post
-
UK PM Johnson: MHRA is already set to assess Novavax vaccine after phase 3 trials showed 89.3% efficacy
FXstreet.com